![]() |
NKF
K/DOQI GUIDELINES 2000
|
||||||
![]() |
![]() |
![]() |
![]() |
||||
GUIDELINES FOR VASCULAR ACCESS
III. NKF-K/DOQI CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS: UPDATE 2000
NOTE: The citation for these guidelines should read as follows: National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Vascular Access, 2000. Am J Kidney Dis 37:S137-S181, 2001 (suppl 1)
Acronyms and Abbreviations
| Abbreviation | Term | Abbreviation | Term | |
| A | arterial | NKF | National Kidney Foundation | |
| ASA | acetylsalicylic acid | PTA | percutaneous transluminal angioplasty | |
| AV | arteriovenous | PTFE | polytetrafluoroethylene | |
| BFR | blood flow rate | QA | quality assurance | |
| BUN | blood urea nitrogen | R | recirculation | |
| CDC | Centers for Disease Control | S | sample | |
| CKD | chronic kidney disease | t | time | |
| CQI | continuous quality improvement | URR | urea reduction ratio | |
| DOQI | Dialysis Outcomes Quality Initiative | USRDS | United States Renal Data System | |
| ESRD | end-stage renal disease | V | volume of distribution (when referring to urea, V = total body water) | |
| IV | intravenous | V | venous | |
| NCDS | National Cooperative Dialysis Study | VA | vascular access |
| © 2001 National Kidney Foundation, Inc web version created by cyberNephrologyTM and The Nephron Information Center |